Ser Yue Loo

1.0k total citations
13 papers, 736 citations indexed

About

Ser Yue Loo is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Ser Yue Loo has authored 13 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Toxicology. Recurrent topics in Ser Yue Loo's work include Bioactive Compounds and Antitumor Agents (2 papers), Glutathione Transferases and Polymorphisms (2 papers) and RNA Interference and Gene Delivery (2 papers). Ser Yue Loo is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Glutathione Transferases and Polymorphisms (2 papers) and RNA Interference and Gene Delivery (2 papers). Ser Yue Loo collaborates with scholars based in Singapore, Australia and United States. Ser Yue Loo's co-authors include Alan Prem Kumar, Gautam Sethi, Chern Chiuh Woo, Chun Wei Yap, Muthu K. Shanmugam, Peramaiyan Rajendran, Kanjoormana Aryan Manu, Shazib Pervaiz, Feng Li and Celestial T. Yap and has published in prestigious journals such as British Journal of Pharmacology, Biological reviews/Biological reviews of the Cambridge Philosophical Society and Biomacromolecules.

In The Last Decade

Ser Yue Loo

12 papers receiving 722 citations

Peers

Ser Yue Loo

CAM

TOXIC

ONCOL

Chuan‐Chou Tu Taiwan

Chirine El‐Baba Lebanon

Lalitha Ramachandran Singapore

Tina H. Ong Singapore

Bassant M. Barakat Egypt

Julie A. Arlotti United States

Varadharajan Thiyagarajan Taiwan

Debasish Basak United States

Qianmei Zhou China

Youn Kyung Choi South Korea

Chuan‐Chou Tu Taiwan

Ser Yue Loo

329 ×0.8

161 ×0.9

108 ×0.7

CAM

92 ×0.7

TOXIC

168 ×1.4

ONCOL

Citations per year, relative to Ser Yue Loo Ser Yue Loo (= 1×) peers Chuan‐Chou Tu

Countries citing papers authored by Ser Yue Loo

Since Specialization

Citations

This map shows the geographic impact of Ser Yue Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ser Yue Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ser Yue Loo more than expected).

Fields of papers citing papers by Ser Yue Loo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ser Yue Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ser Yue Loo. The network helps show where Ser Yue Loo may publish in the future.

Co-authorship network of co-authors of Ser Yue Loo

This figure shows the co-authorship network connecting the top 25 collaborators of Ser Yue Loo. A scholar is included among the top collaborators of Ser Yue Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ser Yue Loo. Ser Yue Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lam, Jian Hang, Ser Yue Loo, Shaoqiong Liu, et al.. (2025). Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery. Biomacromolecules. 26(4). 2444–2457.

Bindra, Anivind Kaur, Shaoqiong Liu, Ser Yue Loo, et al.. (2024). Amphiphilic Block Copolymer Nanostructures as a Tunable Delivery Platform: Perspective and Framework for the Future Drug Product Development. Biomacromolecules. 25(2). 541–563. 20 indexed citations

Loo, Ser Yue, Nicholas Syn, Amudha Deivasigamani, et al.. (2021). Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. Cell Death Discovery. 7(1). 265–265. 12 indexed citations

Wu, Zhengwei, et al.. (2021). Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer. Cancers. 13(6). 1316–1316. 7 indexed citations

Loo, Ser Yue, Jayshree L. Hirpara, Vijay Pandey, et al.. (2016). Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma. Antioxidants and Redox Signaling. 25(6). 283–299. 45 indexed citations

Li, Feng, Muthu K. Shanmugam, Kodappully Sivaraman Siveen, et al.. (2015). Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers. Oncotarget. 6(7). 5147–5163. 72 indexed citations

Loo, Ser Yue, Arpita Datta, Kodappully Sivaraman Siveen, et al.. (2015). microRNAsin breast cancer: regulatory roles governing the hallmarks of cancer. Biological reviews/Biological reviews of the Cambridge Philosophical Society. 91(2). 409–428. 90 indexed citations

Datta, Arpita, Ser Yue Loo, Baohua Huang, et al.. (2014). SPHK1 regulates proliferation and survival responses in triple-negative breast cancer. Oncotarget. 5(15). 5920–5933. 65 indexed citations

Subramaniam, Aruljothi, Ser Yue Loo, Peramaiyan Rajendran, et al.. (2013). An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins. APOPTOSIS. 18(10). 1175–1187. 37 indexed citations

10.

Kumar, Alan Prem, Ser Yue Loo, Tuan Zea Tan, et al.. (2013). Manganese Superoxide Dismutase Is a Promising Target for Enhancing Chemosensitivity of Basal-Like Breast Carcinoma. Antioxidants and Redox Signaling. 20(15). 2326–2346. 32 indexed citations

11.

Loo, Ser Yue, et al.. (2012). NHE-1: A Promising Target for Novel Anti-cancer Therapeutics. Current Pharmaceutical Design. 18(10). 1372–1382. 63 indexed citations

12.

Woo, Chern Chiuh, et al.. (2011). Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway. Biochemical Pharmacology. 82(5). 464–475. 180 indexed citations

13.

Rajendran, Peramaiyan, Feng Li, Kanjoormana Aryan Manu, et al.. (2010). γ‐Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro‐apoptotic and chemosensitizing agent. British Journal of Pharmacology. 163(2). 283–298. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact